Please use this identifier to cite or link to this item:
Title: Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity
Authors: Pushkina, Ekaterina A
Borisevich, Sophia S
Galochkina, Anastasia V
Garshinina, Angelica V
Shtro, Anna A
Egorova, Anna A
Sokolova, Anastasia S
Khursan, Sergey L
Yarovaya, Olga I
Salakhutdinov, Nariman F
Zarubaev, Vladimir V. 
Keywords: Antivirals;Camphecene;Drug resistance;Hemagglutinin;Influenza virus;Pathogenicity
Issue Date: 2018
Publisher: Elsevier
Journal: Virology 
Abstract: Due to the ability of influenza virus to develop drug resistance, the search for novel antivirals is an important goal of medical science and health care systems. We assessed the ability of the influenza virus to develop resistance to the hemagglutinin inhibitor camphecene and characterized laboratory-selected resistant strains. We showed by electron microscopy that camphecene decreases the number of virions fusing their envelopes with endosomal membranes. A 160-fold decrease in virus susceptibility was observed after six passages in cells. This was associated with the emergence of a V458L mutation in the HA2 subunit of HA and with a decrease in viral pathogenicity. Molecular modeling predicts that this substitution results in a more stable HA molecule compared to wild-type HA; and an altered camphecene-binding site. Therefore, despite the relatively rapid development of resistance, camphecene remains promising as a potential antiviral due to the low pathogenicity of resistant viruses that may arise.
ISSN: 0042-6822
DOI: 10.1016/j.virol.2018.08.011
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Apr 20, 2019

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.